Leptin prevents hippocampal synaptic disruption and neuronal cell death induced by amyloid β

Neurobiology of Aging

Volumn 34, Issue 1, 2013, Pages 226-237

  Doherty, Gayle H ^a   Beccano Kelly, Dayne ^b   Yan, Shi Du ^c   Gunn Moore, Frank J ^a   Harvey, Jenni ^b  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF KANSAS   (United States)

Author keywords

AMPA receptor trafficking; Amyloid beta; Endophilin I; Leptin; Synaptic plasticity

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; ENDOPHILIN; ENDOPHILIN 1; GLUTAMATE RECEPTOR 1; LEPTIN; PHOSPHATIDYLINOSITOL 3 KINASE; STAT3 PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; HORMONE ACTION; IN VITRO STUDY; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MALE; NERVE CELL NECROSIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SYNAPTIC TRANSMISSION;

AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BIOPHYSICS; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTRIC STIMULATION; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; LEPTIN; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEURONS; NEUROPROTECTIVE AGENTS; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; RATS; RECEPTORS, AMPA; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SYNAPSES; SYNAPTIC POTENTIALS; TAU PROTEINS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84868141733     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.08.003     Document Type: Article

References (45)

1. Abe K., Saito H. Both oxidative stress-dependent and independent effects of amyloid beta protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Brain Res 1999, 830:146-154.
2. Anderson W.W., Collingridge G.L. Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions. J. Neurosci. Methods 2007, 162:346-356.
3. Atwood C.S., Moir R.D., Huang X., Scarpa R.C., Bacarra N.M., Romano D.M., Hartshorn M.A., Tanzi R.E., Bush A.I. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem 1998, 273:12817-12826.
4. Barger S.W., Hörster D., Furukawa K., Goodman Y., Krieglstein J., Mattson M.P. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:9328-9332.
5. Billings L.M., Green K.N., McGaugh J.L., LaFerla F.M. Learning decreases A beta*56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice. J. Neurosci 2007, 27:751-761.
6. Cerpa W., Dinamarca M.C., Inestrosa N.C. Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses. Curr. Alzheimer Res 2008, 5:233-243.
7. Doherty G.H., Oldreive C., Harvey J. Neuroprotective actions of leptin on central and peripheral neurons in vitro. Neuroscience 2008, 154:1297-1307.
8. Farr S.A., Banks W.A., Morley J.E. Effects of leptin on memory processing. Peptides 2006, 27:1420-1425.
9. Fernández-Galaz C., Fernández-Agulló T., Campoy F., Arribas C., Gallardo N., Andrés A., Ros M., Carrascosa J.M. Decreased leptin uptake in hypothalamic nuclei with ageing in Wistar rats. J. Endocrinol 2001, 171:23-32.
10. Fewlass D.C., Noboa K., Pi-Sunyer F.X., Johnston J.M., Yan S.D., Tezapsidis N. Obesity-related leptin regulates Alzheimer's Abeta. FASEB J 2004, 18:1870-1878.
11. Grace E.A., Rabiner C.A., Busciglio J. Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's Disease. Neuroscience 2002, 114:265-273.
12. Greco S.J., Sarkar S., Johnston J.M., Tezapsidis N. Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. Biochem. Biophys. Res. Commun 2009, 380:98-104.
13. Greenberg S.M., Koo E.H., Selkoe D.J., Qiu W.Q., Kosik K.S. Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc. Natl. Acad. Sci. USA 1994, 91:7104-7108.
14. Guo Z., Jiang H., Xu X., Duan W., Mattson M.P. Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization. J. Biol. Chem 2008, 283:1754-1763.
15. Harvey J. Leptin: a diverse regulator of neuronal function. J. Neurochem 2007, 100:307-313.
16. Hsieh H., Boehm J., Sato C., Iwatsubo T., Tomita T., Sisodia S., Malinow R. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 2006, 52:831-843.
17. Li X.L., Aou S., Oomura Y., Hori N., Fukunaga K., Hori T. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience 2002, 113:607-615.
18. Li S., Hong S., Shepardson N.E., Walsh D.M., Shankar G.M., Selkoe D. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009, 62:788-801.
19. Lieb W., Beiser A.S., Vasan R.S., Tan Z.S., Au R., Harris T.B., Roubenoff R., Auerbach S., DeCarli C., Wolf P.A., Seshadri S. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 2009, 302:2565-2572.
20. Liu S.J., Gasperini R., Foa L., Small D.H. Amyloid-beta decreases cell-surface AMPA receptors by increasing intracellular calcium and phosphorylation of GluR2. J. Alzheimers Dis 2010, 21:655-666.
21. Morrison C.D., White C.L., Wang Z., Lee S.Y., Lawrence D.S., Cefalu W.T., Zhang Z.Y., Gettys T.W. Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age. Endocrinology 2007, 148:433-440.
22. Moult P.R., Cross A., Santos S.D., Carvalho A.L., Lindsay Y., Connolly C.N., Irving A.J., Leslie N.R., Harvey J. Leptin regulates AMPA receptor trafficking via PTEN inhibition. J. Neurosci 2010, 30:4088-4101.
23. Moult P.R., Harvey J. NMDA receptor subunit composition determines the polarity of leptin-induced synaptic plasticity. Neuropharmacology 2011, 61:924-936.
24. Moult P.R., Milojkovic B., Harvey J. Leptin reverses long-term potentiation at hippocampal CA1 synapses. J. Neurochem 2009, 108:685-696.
25. O'Malley D., MacDonald N., Mizielinska S., Connolly C.N., Irving A.J., Harvey J. Leptin promotes rapid dynamic changes in hippocampal dendritic morphology. Mol. Cell. Neurosci 2007, 35:559-572.
26. Oldreive C.E., Doherty G.H. Effects of tumour necrosis factor-alpha on developing cerebellar granule and Purkinje neurons in vitro. J. Mol. Neurosci 2010, 42:44-52.
27. Oldreive C.E., Harvey J., Doherty G.H. Neurotrophic effects of leptin on cerebellar Purkinje but not granule neurons in vitro. Neurosci. Lett 2008, 438:17-21.
28. Peralta S., Carrascosa J.M., Gallardo N., Ros M., Arribas C. Ageing increases SOCS-3 expression in rat hypothalamus: effects of food restriction. Biochem. Biophys. Res. Commun 2002, 296:425-428.
29. Power D.A., Noel J., Collins R., O'Neill D. Circulating leptin levels and weight loss in Alzheimer's disease patients. Dement. Geriatr. Cogn. Disord 2001, 12:167-170.
30. Ren Y., Xu H.W., Davey F., Taylor M., Aiton J., Coote P., Fang F., Yao J., Chen D., Chen J.X., Yan S.D., Gunn-Moore F.J. Endophilin I expression is increased in the brains of Alzheimer disease patients. J. Biol. Chem 2008, 283:5685-5691.
31. Russo V.C., Metaxas S., Kobayashi K., Harris M., Werther G.A. Antiapoptotic effects of leptin in human neuroblastoma cells. Endocrinology 2004, 145:4103-4112.
32. Saxena N.K., Titus M.A., Ding X., Floyd J., Srinivasan S., Sitaraman S.V., Anania F.A. Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J 2004, 18:1612-1614.
33. Sayre L.M., Perry G., Harris P.L., Liu Y., Schubert K.A., Smith M.A. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J. Neurochem 2000, 74:270-279.
34. Scarpace P.J., Matheny M., Moore R.L., Tümer N. Impaired leptin responsiveness in aged rats. Diabetes 2000, 49:431-435.
35. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., Regan C.M., Walsh D.M., Sabatini B.L., Selkoe D.J. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med 2008, 14:837-842.
36. Shanley L.J., Irving A.J., Harvey J. Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. J. Neurosci 2001, 21:RC186.
37. Simmons L.K., May P.C., Tomaselli K.J., Rydel R.E., Fuson K.S., Brigham E.F., Wright S., Lieberburg I., Becker G.W., Brems D.N., et al. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol 1994, 45:373-379.
38. Spiegelman B.M., Flier J.S. Obesity and the regulation of energy balance. Cell 2001, 104:531-543.
39. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci 2008, 11:309-317.
40. Stranahan A.M., Lee K., Martin B., Maudsley S., Golden E., Cutler R.G., Mattson M.P. Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice. Hippocampus 2009, 19:951-961.
41. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416:535-539.
42. Wayner M.J., Armstrong D.L., Phelix C.F., Oomura Y. Orexin-A (Hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats in vivo. Peptides 2004, 25:991-996.
43. Weng Z., Signore A.P., Gao Y., Wang S., Zhang F., Hastings T., Yin X.M., Chen J. Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. J. Biol. Chem 2007, 282:34479-34491.
44. Weston M.C., Nehring R.B., Wojcik S.M., Rosenmund C. Interplay between VGLUT isoforms and endophilin A1 regulates neurotransmitter release and short-term plasticity. Neuron 2011, 69:1147-1159.
45. White A.R., Huang X., Jobling M.F., Barrow C.J., Beyreuther K., Masters C.L., Bush A.I., Cappai R. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways. J. Neurochem 2001, 76:1509-1520.